INVO Bioscience is a commercial-stage fertility company focused on the expansion of the assisted reproductive technology marketplace through its flagship product, according to a Jan. 3 news release from the company. The INVOCell is a medical device designed to allow fertilization and early embryo development to take place in vivo within a patient’s body.
Dr. Holmström joins INVO with more than two decades of experience as a gynecologist. She most recently served as a professor in obstetrics and gynecology at the University of South Florida Morsani College of Medicine in Tampa.
She also led a full-time academic practice at USF Physicians Group for 18 years while at USF, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.